Sathyanarayanan Sriram's Form 4 filing
Codiak BioSciences, Inc. (CDAK) · filed Feb 21, 2023
- Accession no.
- 0000899243-23-005694
- Filed
- Feb 21, 2023
- Trade date
- Aug 16, 2022-Feb 17, 2023
- Filing delay
- 189 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $6.47K. It was filed 189 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sathyanarayanan SriramCIK 0001867898 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 | Common Stock | MOption exerciseAcquired | +7,350 | – | – | 9,102 | Direct | |
| Aug 17, 2022 | Common Stock | SSaleDisposed | −2,283 | $2.21 | −$5,045.43 | 6,819 | Direct | |
| Feb 16, 2023 | Common Stock | MOption exerciseAcquired | +7,350 | – | – | 14,169 | Direct | |
| Feb 17, 2023 | Common Stock | SSaleDisposed | −2,407 | $0.59 | −$1,420.13 | 11,762 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 | Common Stock | MOption exerciseDisposed | −7,350 | $0.00 | $0 | 22,050 | Direct | |
| Feb 16, 2023 | Common Stock | MOption exerciseDisposed | −7,350 | $0.00 | $0 | 14,700 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.